schliessen

Filtern

 

Bibliotheken

7.

A low-toxicity IL-2-based immunocytokine retains antitumor activity despite its high degree of IL-2 receptor selectivity.
by Gillies, Stephen D

Clinical cancer research : an official journal of the American Association for Cancer Research, June 1, 2011, Vol.17(11), pp.3673-3685

9.

Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance
by Gao, Beixue

Proceedings of the National Academy of Sciences of the United States of America, 17 January 2012, Vol.109(3), pp.899-904

10.

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients
by Weiss, Laurence

Proceedings of the National Academy of Sciences of the United States of America, 08 June 2010, Vol.107(23), pp.10632-7

12.

Old cancer drug gets fresh look.
by Ledford, Heidi

Nature, May 29, 2014, Vol.509(7502), pp.541-542

13.

MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation
by Trifari, Sara

Proceedings of the National Academy of Sciences, USA, Nov 2013, Vol.110(46), p.18608

14.

Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance
by Papatriantafyllou, Maria

Proceedings of the National Academy of Sciences, USA, Jan 31, 2012, Vol.109(5), pp.1631-1636

15.

Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8⁺ T cell
by Thaventhiran , James E. D. 2012

Proceedings of the National Academy of Sciences of the United States of America, 2012, Vol.109(33), pp.E2223-E2229

2012

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 44.630 Hits